γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin
暂无分享,去创建一个
Kathleen R. Cho | Eric R. Fearon | E. Fearon | F. Kolligs | Masachika Tani | K. M. Hajra | G. Hu | Frank T. Kolligs | Barbara Kolligs | Karen M. Hajra | Gang Hu | M. Tani | B. Kolligs | K. Cho
[1] A. Millar,et al. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. , 1999, Cancer research.
[2] M. Bienz. APC: the plot thickens. , 1999, Current opinion in genetics & development.
[3] L. Larue,et al. Lack of beta-catenin affects mouse development at gastrulation. , 1995, Development.
[4] P. Polakis,et al. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[5] Hans Clevers,et al. XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.
[6] Michael Kühl,et al. Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.
[7] B. Herrmann,et al. Nuclear localization of β-catenin by interaction with transcription factor LEF-1 , 1996, Mechanisms of Development.
[8] E. Fuchs,et al. De Novo Hair Follicle Morphogenesis and Hair Tumors in Mice Expressing a Truncated β-Catenin in Skin , 1998, Cell.
[9] S. Hirohashi,et al. Beta-catenin mutation in carcinoma of the uterine endometrium. , 1998, Cancer research.
[10] J. Palacios,et al. β-Catenin Expression Pattern in Stage I and II Ovarian Carcinomas : Relationship with β-Catenin Gene Mutations, Clinicopathological Features, and Clinical Outcome , 1999 .
[11] L. Larue,et al. Lack of beta-catenin affects mouse development at gastrulation. , 1995, Development.
[12] T. Maniatis,et al. A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. , 1999, Genes & development.
[13] Y. Nakamura,et al. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. , 1998, Cancer research.
[14] P. Cohen,et al. PDK1, one of the missing links in insulin signal transduction? 1 , 1997, FEBS letters.
[15] Satoshi Ikeda,et al. Axin Directly Interacts with Plakoglobin and Regulates Its Stability* , 1999, The Journal of Biological Chemistry.
[16] P. Cohen,et al. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. , 1993, The Biochemical journal.
[17] M. Buendia,et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Wieschaus,et al. A Drosophila homolog of the tumor suppressor gene adenomatous polyposis coli down-regulates beta-catenin but its zygotic expression is not essential for the regulation of Armadillo. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] Rudolf Grosschedl,et al. Modulation of Transcriptional Regulation by LEF-1 in Response to Wnt-1 Signaling and Association with β-Catenin , 1998, Molecular and Cellular Biology.
[20] Paul Polakis,et al. The oncogenic activation of β-catenin , 1999 .
[21] Paul Polakis,et al. Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.
[22] K. Kinzler,et al. Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.
[23] M. Kirschner,et al. Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. , 2000, Molecular cell.
[24] T. Akiyama,et al. Down-regulation of β-Catenin by the Colorectal Tumor Suppressor APC Requires Association with Axin and β-Catenin* , 2000, The Journal of Biological Chemistry.
[25] D L Rimm,et al. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[26] Benjamin Geiger,et al. Differential Nuclear Translocation and Transactivation Potential of β-Catenin and Plakoglobin , 1998, The Journal of cell biology.
[27] H. Schwarz,et al. Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice. , 1999, Development.
[28] C. Raffel,et al. Sporadic Medulloblastomas Contain Oncogenic β-Catenin Mutations , 1998 .
[29] B. Geiger,et al. Suppression of tumorigenicity by plakoglobin: an augmenting effect of N- cadherin , 1996, The Journal of cell biology.
[30] Yusuke Nakamura,et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 , 2000, Nature Genetics.
[31] W. Birchmeier,et al. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton , 1994, The Journal of cell biology.
[32] M. Peifer,et al. The segment polarity gene armadillo encodes a functionally modular protein that is the Drosophila homolog of human plakoglobin , 1990, Cell.
[33] O. MacDougald,et al. Glycogen Synthase Kinase 3 Is an Insulin-Regulated C/EBPα Kinase , 1999, Molecular and Cellular Biology.
[34] Bert Vogelstein,et al. Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer , 1998 .
[35] R. Benarous,et al. The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell , 1999, Current Biology.
[36] H. Clevers,et al. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. , 1999, Science.
[37] W. Birchmeier,et al. Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart , 1996, The Journal of cell biology.
[38] Hans Clevers,et al. Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.
[39] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[40] B. Geiger,et al. Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer. , 1998, Current opinion in cell biology.
[41] S. Hirohashi,et al. Association of plakoglobin with APC, a tumor suppressor gene product, and its regulation by tyrosine phosphorylation. , 1994, Biochemical and biophysical research communications.
[42] R. Koski,et al. Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors. , 1992, Cancer research.
[43] R. Nusse,et al. Wnt signaling: a common theme in animal development. , 1997, Genes & development.
[44] Paul Polakis,et al. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors , 1999, Oncogene.
[45] E. Wieschaus,et al. The segment polarity gene armadillo interacts with the wingless signaling pathway in both embryonic and adult pattern formation. , 1991, Development.
[46] M. Kitagawa,et al. An F‐box protein, FWD1, mediates ubiquitin‐dependent proteolysis of β‐catenin , 1999, The EMBO journal.
[47] K. Kinzler,et al. Apoptosis and APC in colorectal tumorigenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[48] R. Nusse,et al. β-catenin: a key mediator of Wnt signaling , 1998 .
[49] M. Peifer,et al. Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. , 2000, Science.
[50] P. Soballe,et al. Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. , 1997, Cancer research.
[51] C. Albanese,et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[52] S. Albrecht,et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. , 1999, Cancer research.
[53] C. Dang,et al. Neoplastic Transformation of RK3E by Mutant β-Catenin Requires Deregulation of Tcf/Lef Transcription but Not Activation of c-myc Expression , 1999, Molecular and Cellular Biology.
[54] Stephen J. Elledge,et al. The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro , 1999 .
[55] D. Rimm,et al. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. , 1999, The American journal of pathology.
[56] D. Rimm,et al. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. , 1999, Cancer research.
[57] J. K. Scott,et al. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines. , 1988, Oncogene.
[58] E. Gelmann,et al. β-Catenin Mutations in Human Prostate Cancer , 1998 .
[59] Y. Nakamura,et al. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. , 1998, Cancer research.
[60] A. Sparks,et al. Identification of c-MYC as a target of the APC pathway. , 1998, Science.
[61] H. Schwarz,et al. Desmosomal localization of β-catenin in the skin of plakoglobin null -mutant mice , 1998 .
[62] P. Polakis,et al. The APC Protein and E-cadherin Form Similar but Independent Complexes with α-Catenin, β-Catenin, and Plakoglobin (*) , 1995, The Journal of Biological Chemistry.
[63] S. H. Lee,et al. Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. , 1999, Cancer research.
[64] M. Taketo,et al. Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene , 1999, The EMBO journal.
[65] W. Nelson,et al. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. , 1997, Current opinion in cell biology.
[66] 猪股雅史. Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients(家族性大腸腺腫症患者の大腸上皮細胞における細胞間接着分子β-カテニンの発現変化) , 1997 .
[67] K. Kinzler,et al. Association of the APC tumor suppressor protein with catenins. , 1993, Science.
[68] K. Kinzler,et al. PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999, Cell.
[69] F. van Roy,et al. Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. , 1999, Cancer research.
[70] Frank McCormick,et al. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.